Trademark Overview
On Thursday, May 16, 2019, a trademark application was filed for ANDUELO with the United States Patent and Trademark Office. The USPTO has given the ANDUELO trademark a serial number of 79261542. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, July 25, 2019. This trademark is owned by Glaxo Group Limited. The ANDUELO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines